Diencephalic involvement in generalized lipodystrophy: rationale and treatment with the neuroleptic agent, pimozide

Acta Endocrinol (Copenh). 1974 Oct;77(2):209-20. doi: 10.1530/acta.0.0770209.
No abstract available

MeSH terms

  • Animals
  • Child
  • Chlorpromazine / pharmacology
  • Chlorpromazine / therapeutic use
  • Cholesterol / blood
  • Corticotropin-Releasing Hormone / blood
  • Depression, Chemical
  • Diencephalon / drug effects*
  • Diencephalon / metabolism
  • Female
  • Gonadotropin-Releasing Hormone / blood
  • Growth Hormone / blood
  • Humans
  • Hydrocortisone / blood
  • Insulin / blood
  • Lipids / blood
  • Lipodystrophy / drug therapy*
  • Lipodystrophy / metabolism
  • Liver Function Tests
  • Male
  • Pimozide / pharmacology
  • Pimozide / therapeutic use*
  • Rats
  • Stimulation, Chemical
  • Time Factors
  • Triglycerides / blood

Substances

  • Insulin
  • Lipids
  • Triglycerides
  • Pimozide
  • Gonadotropin-Releasing Hormone
  • Growth Hormone
  • Corticotropin-Releasing Hormone
  • Cholesterol
  • Chlorpromazine
  • Hydrocortisone